retatrutide side effects clinical trials 2025 Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation retatrutide side effects clinical trials

The GLP-1 Access Gap: Mapping Who Can Actually Afford Americas Miracle Weight-Loss Drugs, The Health Management Academy, February 4, 2026, Virta internal analysis of commercially enrolled population enrolled since Q2 2025 McKenzie, A.L., Athinarayanan, S.J

Morning: ginger tea

The medication hit pharmacy shelves in early January

CrossRef Research Progress on the Biological Function, Disease-Driving Mechanism and Clinical Targeting Strategies of G3BP2 Yao Chen, Qi Deng, Li-Ling Yang, Ai-Ling Jiang, Rong Zhang, Qi-Bing Yan, Yong-Kang Wu Molecules .2026

GLP-1s became a catalyst for a host of cosmetic procedures that people never wanted or anticipated needing